SERI Lugano Launches International Scientific Outreach Initiative on Light-Based Neuroscience and Pineal Gland Research
18.5.2026 15:38:00 CEST | Business Wire | Press release
As scientific interest in light-based stimulation, neuroendocrine regulation, and integrative medicine continues to grow internationally, the Switzerland Eye Research Institute (SERI Lugano) has launched a new international scientific outreach initiative focused on public engagement and interdisciplinary research communication in neuroscience and cellular modulation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260515840289/en/
Ophthalmologist Roberto Pinelli explains, in an engaging personal narrative style, his unique methods for using a combination of light, sound, and nutraceuticals to non-invasively activate the pineal gland to promote cellular rejuvenation, decrease aging, and improve overall well-being. Supported by case studies and peer-reviewed research, Pinelli’s method centers on using photons to convey vibrational energy through the eyes to target areas of the body with the sinergic use of sound vibrations and specific nutraceuticals. He shows the potent effects this has on overall wellbeing and mental health as it can improve memory, mental clarity, and self-awareness. His techniques also have positive effects on the body such as helping to heal degenerative diseases like AMD, retinal degenerations, Alzheimer’s, rheumatoid arthritis, and Parkinson’s.
The initiative aims to promote broader understanding of emerging research involving photobiomodulation, circadian biology, neuroendocrine processes, and the interaction between light, sound frequencies, and cellular function.
As part of this initiative, SERI Lugano is supporting the international publication and distribution of Awakening the Pineal Gland – Cellular Rejuvenation through Light and Sound, a new volume written by SERI Lugano founder and director Roberto Pinelli and published in the United States by Inner Traditions.
The pineal gland, a neuroendocrine structure historically associated with circadian regulation and melatonin production, has increasingly become an area of scientific interest in studies exploring the relationship between light exposure, brain activity, metabolism, and cellular signaling. Recent developments in neuroscience and photobiomodulation research have contributed to renewed attention toward the biological role of light in human physiology.
Photobiomodulation — a treatment that delivers intermittent low-frequency light through the pupillary foramen with the aim of modulating specific cellular functions — represents one of the areas explored within the initiative, together with infrasound stimulation and nutraceutical support strategies.
Researchers and clinicians affiliated with SERI Lugano are currently investigating the interaction between light-based stimulation, mitochondrial activity, circadian mechanisms, and neuroendocrine regulation, with particular attention to potential applications in integrative and regenerative medicine (Pinelli R. et al, “Combined pulses of light and sound in the retina with nutraceuticals may enhance the recovery of foveal holes”. Archives Italiennes de Biologie, 160: 3-21, 2022).
The initiative also promotes interdisciplinary dialogue between contemporary scientific investigation and historical perspectives on light and consciousness found in ancient civilizations, including Egyptian and Sumerian traditions. According to SERI Lugano, revisiting historical interpretations of human physiology may contribute to broader cultural reflection alongside modern scientific research.
“Scientific communication should help create bridges between advanced research, clinical observation, and public understanding,” said Roberto Pinelli, founder and director of SERI Lugano. “Our goal is to encourage interdisciplinary dialogue around the role of light, neuroscience, and cellular function in human physiology.”
The initiative reflects SERI Lugano’s broader commitment to integrating ophthalmology, neuroscience, photobiomodulation, and cellular research within an international scientific and educational framework.
The volume Awakening the Pineal Gland is distributed in the United States by Simon & Schuster and is available through major international platforms, including Amazon.com.
About Switzerland Eye Research Institute (SERI Lugano)
The Switzerland Eye Research Institute (SERI Lugano), based in Lugano, Switzerland, is an independent research and clinical institute focused on ophthalmology, neuroscience, photobiomodulation, and interdisciplinary research involving light-based technologies, neuroendocrine regulation, and cellular function.
The institute promotes integrative approaches combining clinical activity, scientific research, and public scientific communication.
Learn more:
www.seri-lugano.ch
View source version on businesswire.com: https://www.businesswire.com/news/home/20260515840289/en/
Contacts
Media Contact
Switzerland Eye Research Institute (SERI Lugano)
Lugano, Switzerland
E-mail: info@seri-lugano.ch
Tel.: +41 91 993 13 01
About Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London
+44 20 7626 1982http://www.businesswire.co.uk
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
H.I.G. Capital Announces the Sale of DGS S.p.A.11.6.2024 12:00:00 CEST | Press release
H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with $62 billion of capital under management, is pleased to announce that an affiliate has signed a definitive agreement to sell its portfolio company, DGS S.p.A. (“DGS” or the “Group”), a leading firm in the Italian Information Technology market, to DGS Co-Founders and management team in partnership with ICG, a global alternative asset manager. Since its inception in 1997, DGShas supported blue-chip customers in the design, integration, and maintenance of complex IT systems, with a specialization in digital transformation and cybersecurity services. The Group currently has over 1,900 employees, revenues of approximately €300 million, and maintains a group of highly loyal clientele. During H.I.G.’s ownership, DGS has tripled in size and consolidated its position as a leading Italian firm in cybersecurity services and digital transformation. DGS offers its clients sophisticated and proprietary digital transformation
Evertas Names Nick Selby Head of European Underwriting11.6.2024 12:00:00 CEST | Press release
Evertas, the world’s first crypto insurance company, has named Nick Selby as its new Head of European Underwriting. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611141887/en/ Nick Selby, Executive Vice President and Head of European Underwriting at Evertas (Photo: Business Wire) Selby, an accomplished information and physical security professional, brings two decades of expertise in public and private sector information security, physical security, and complex incident handling, as well as seven years of experience leading teams securing billions of dollars in cryptoassets. Previously, his roles included VP of the Software Assurance Practice at Trail of Bits, Chief Security Officer at Paxos Trust Company, and Director of Cyber Intelligence and Investigations at the NYPD Intelligence Bureau. “Nick is an extremely valuable addition to our European team,” said Evertas CEO and Co-Founder J. Gdanski. “His public and private
Owlet utvider globalt fotavtrykk med lanseringen av medisinsk-sertifisert Dream Sock™ i Storbritannia og over hele Europa11.6.2024 11:00:00 CEST | Pressemelding
Owlet, Inc. («Owlet» or the «Company») (NYSE:OWLT), pioneren innen smart spedbarnsovervåking, kunngjør i dag den britiske og europeiske lanseringen av Dream Sock. Dette er en smart babymonitor med levende helseavlesninger og varsler for friske spedbarn mellom 0-18 måneder og 2,5-13,6 kg. Dette innovative medisinske utstyret gir foreldre helse og viktig informasjon i sanntid, noe som gir uovertruffen trygghet. Denne pressemeldingen inneholder multimedia. Se hele pressemeldingen her: https://www.businesswire.com/news/home/20240611820341/no/ (Photo: Business Wire) «Vi er svært stolte over å lansere Dream Sock til omsorgspersoner over hele Storbritannia og Europa og gi millioner av foreldre mer trygghet mens babyen sover,» sa Kurt Workman, Owlets administrerende direktør og medgründer. «Dream Sock er nå et globalt produkt som er anerkjent som medisinsk nøyaktig og trygt, etter å ha gjennomgått regulatoriske autorisasjoner og sertifiseringer innenfor flere geografier. I dag er misjonen vår
V-Nova Surpasses 1000 Patent Milestone in Media Technology Innovation11.6.2024 10:00:00 CEST | Press release
V-Nova, a leading provider of data compression solutions, video compression technology, XR technology, AI acceleration and parallel processing for a multitude of industries including media and entertainment, today announced its milestone achievement of 1000 active technology patents. This accomplishment underscores V-Nova’s dedication to research and development and its commitment to protecting its intellectual property globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240611724561/en/ V-Nova’s patent portfolio spans more than 50 different jurisdictions. Including over 400 patents in Europe, over 200 in the Americas, over 100 in the United States specifically, and over 200 in Asia. V-Nova forged new directions in data processing to enhance digital experiences, maximize efficiency, reduce costs, and increase sustainability. The company leads the way with key international data compression standards for the video indust
Alipay+ Reveals Top Scorer Trophy Design for UEFA EURO 2024™11.6.2024 09:24:00 CEST | Press release
Alipay+, a suite of cross-border mobile payment and digitalization technology solutions operated by Ant International and an Official Partner of UEFA EURO 2024™, today revealed the trophy that will be awarded to the most prolific marksman at the UEFA EURO 2024™ finale on July 14 in Berlin, Germany. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240610328619/en/ The UEFA Top Scorer Trophy presented by Alipay+ is unveiled for UEFA EURO 2024™ (Photo: Business Wire) Sculpted in the shape of the Chinese character “支” (pronounced zhi, and meaning payment as well as support), the trophy reflects Alipay+’s dedication to supporting consumers to enjoy seamless payment and a broad choice of deals using their preferred payment methods while traveling abroad. The character also resembles the fleeting moment of a barefooted striker poised to shoot, evoking the original beauty and power of football – a game that united people across the wo